Ion channel blockers and glioblastoma risk and outcome: a nested case-control and retrospective cohort studies

Oct-16

AUTHORS : Dr Yu-Xiao Yang, MD, MSCE, Department of Medicine, University of Pennsylvania Perelman School of Medicine, 423 Guardian Drive, 733 Blockley Hall, Philadelphia, Pennsylvania 19010, USA – Email: yangy@pennmedicine.upenn.edu – Profile: https://www.med.upenn.edu/apps/faculty/index.php/g275/p18504

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 25(10):1179-1185

DOI : 10.1002/pds.4054

Ion channel blockers and glioblastoma risk and outcome: a nested case-control and retrospective cohort studies

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement